Therapeutic effectiveness of different machines in intense pulsed light treatment of meibomian gland dysfunction

Zhenwei Qin; Yirui Zhu; Jiale Lu; Lin Lin; Yanan Huo; Haoyu Wang; Chen Qiao; Xiangxi Chen; Jianhua Wu; Qingyan Zeng; Xiuming Jin

doi:10.1016/j.aopr.2024.06.002

您当前的位置：

首页 >

文章列表页 >

Therapeutic effectiveness of different machines in intense pulsed light treatment of meibomian gland dysfunction

Full Length Article | 更新时间：2024-12-14

- Therapeutic effectiveness of different machines in intense pulsed light treatment of meibomian gland dysfunction
- Therapeutic effectiveness of different machines in intense pulsed light treatment of meibomian gland dysfunction
- 眼科实践与研究新进展 2024年4卷第4期页码：182-188
- 作者机构：
  
  1. Eye Center of the 2nd Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Provincial Key Lab of Ophthalmology,Hangzhou,China
  2. Wuhan Aier Eye Hospital,Wuhan,China
  3. Hankou Aier Eye Hospital,Wuhan,China
- 作者简介：
- 基金信息：
- DOI：10.1016/j.aopr.2024.06.002
  中图分类号：
- 纸质出版日期：2024，
- 稿件说明：
移动端阅览
Zhenwei Qin, Yirui Zhu, Jiale Lu, 等. Therapeutic effectiveness of different machines in intense pulsed light treatment of meibomian gland dysfunction[J]. 眼科实践与研究新进展, 2024,4(4):182-188.

ZHENWEI QIN, YIRUI ZHU, JIALE LU, et al. Therapeutic effectiveness of different machines in intense pulsed light treatment of meibomian gland dysfunction. [J]. Aopr, 2024, 4(4): 182-188.
Zhenwei Qin, Yirui Zhu, Jiale Lu, 等. Therapeutic effectiveness of different machines in intense pulsed light treatment of meibomian gland dysfunction[J]. 眼科实践与研究新进展, 2024,4(4):182-188. DOI： 10.1016/j.aopr.2024.06.002.

ZHENWEI QIN, YIRUI ZHU, JIALE LU, et al. Therapeutic effectiveness of different machines in intense pulsed light treatment of meibomian gland dysfunction. [J]. Aopr, 2024, 4(4): 182-188. DOI： 10.1016/j.aopr.2024.06.002.

摘要

Abstract

PurposeThis study aimed to determine the therapeutic effectiveness of different machines in intense pulsed light (IPL) treatment of meibomian gland dysfunction (MGD).Methods213 subjects diagnosed with MGD underwent three sessions of IPL treatment in a control (M22) treatment group or experimental (OPL-I) treatment group and were followed up three to four weeks after each session. Tear breakup time (TBUT)

meibomian gland secretion scores (MGSS)

meibomian gland meibum scores (MGMS)

corneal fluorescein staining (CFS) scores

and the Standard Patient Evaluation of Eye Dryness (SPEED) was used to assess eye dryness signs and symptoms at baseline and follow-up visits.ResultsTwo machines had the same working principles except that experimental (OPL-I) group consist of a dual filter system. Both groups showed significant improvements (

0.0001) in TBUT

MGSS

MGMS

CFS scores and SPEED scores. Non-inferiority analysis showed no statistically significant differences in any result between the two groups. Various defects appeared on the filter with the extension of usage time. Spectrophotometry showed that light intensity de

creased to 93.5% ± 0.46% past the first filter.ConclusionsIPL treatment completed with different machines have the same effect on improving the symptoms and signs of MGD. The dual filter system in the IPL machine reduces light intensity by approximately 6.5% without affecting its therapeutic effect. It is a feasible measure to ensure double safety and has the significance of popularization not only for MGD but also in other IPL treatment scenarios.

关键词

Keywords

MGDIPLNon-inferiority analysisDual filter system

references

1 J.D. Nelson, J.P. Craig, E.K. Akpek, et al.TFOS DEWS Ⅱ introduction Ocul Surf, 15 (3) (2017), pp. 269-275, 10.1016/j.jtos.2017.05.005

2 J.D. Nelson, J. Shimazaki, J.M. Benitez-del-Castillo, et al.The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee Invest Ophthalmol Vis Sci, 52 (4) (2011), pp. 1930-1937, 10.1167/iovs.10-6997b

3 A. Tomlinson, A.J. Bron, D.R. Korb, et al.The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee Invest Ophthalmol Vis Sci, 52 (4) (2011), pp. 2006-2049, 10.1167/iovs.10-6997f

4 J. Qiao, X. YanEmerging treatment options for meibomian gland dysfunction Clin Ophthalmol, 7 (2013), pp. 1797-1803, 10.2147/OPTH.S33182

5 J.V. GreinerA single lipiflow thermal pulsation system treatment improves meibomian gland function and reduces dry eye symptoms for 9 months Curr Eye Res, 37 (4) (2012), pp. 272-278, 10.3109/02713683.2011.631721

6 G. Giannaccare, M. Pellegrini, S. Sebastiani, et al.Efficacy of omega-3 fatty acid supplementation for treatment of dry eye disease: a meta-analysis of randomized clinical trials Cornea, 38 (5) (2019), pp. 565-573, 10.1097/ICO.0000000000001884

7 A.R. Thode, R.A. LatkanyCurrent and emerging therapeutic strategies for the treatment of meibomian gland dysfunction (mgd) Drugs, 75 (11) (2015), pp. 1177-1185, 10.1007/s40265-015-0432-8

8 R.R. Vernhardsdottir, M.S. Magno, L. Hynnekleiv, et al.Antibiotic treatment for dry eye disease related to meibomian gland dysfunction and blepharitis - a review Ocul Surf, 26 (2022), pp. 211-221, 10.1016/j.jtos.2022.08.010

9 A. Gade, G.F. Vasile, R. RubensteinIntense Pulsed Light (Ipl) Therapy (2022)

10 R. Toyos, W. McGill, D. BriscoeIntense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; A 3-year retrospective study Photomed Laser Surg, 33 (1) (2015), pp. 41-46, 10.1089/pho.2014.3819

11 R. Toyos, C. Buffa, S. YoungermanCase report- Dry–eye symptoms improve with intense pulsed light treatment EyeWorld, 33 (2005), pp. 41-46

12 R. Arita, S. Fukuoka, N. MorishigeTherapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction Ocul Surf, 17 (1) (2019), pp. 104-110, 10.1016/j.jtos.2018.11.004

13 S. Cote, A.C. Zhang, V. Ahmadzai, et al.Intense pulsed light (ipl) therapy for the treatment of meibomian gland dysfunction Cochrane Db Syst Rev, 3 (3) (2020), Article D13559, 10.1002/14651858.CD013559

14 T.B. FitzpatrickThe validity and practicality of sun-reactive skin types i through vi Arch Dermatol, 124 (6) (1988), pp. 869-871, 10.1001/archderm.124.6.869

15 D.R. Korb, C.A. BlackieMeibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location Cornea, 27 (10) (2008), pp. 1142-1147, 10.1097/ICO.0b013e3181814cff

16 G. Giannaccare, L. Taroni, C. Senni, V. ScorciaIntense pulsed light therapy in the treatment of meibomian gland dysfunction: current perspectives Clin Optom, 11 (2019), pp. 113-126, 10.2147/OPTO.S217639

17 X. Yan, J. Hong, X. Jin, et al.The efficacy of intense pulsed light combined with meibomian gland expression for the treatment of dry eye disease due to meibomian gland dysfunction: a multicenter, randomized controlled trial Eye Contact Lens, 47 (1) (2021), pp. 45-53, 10.1097/ICL.0000000000000711

18 S. HahnUnderstanding noninferiority trials Korean J Pediatr, 55 (11) (2012), pp. 403-407, 10.3345/kjp.2012.55.11.403

19 B. Tashbayev, M. Yazdani, R. Arita, F. Fineide, T.P. UtheimIntense pulsed light treatment in meibomian gland dysfunction: a concise review Ocul Surf, 18 (4) (2020), pp. 583-594, 10.1016/j.jtos.2020.06.002

20 L.A. Schneider, K. Raizner, M. Wlaschek, P. Brenneisen, K. Gethoffer, K. Scharffetter-KochanekUva-1 exposure in vivo leads to an il-6 surge within the skin Exp Dermatol, 26 (9) (2017), pp. 830-832, 10.1111/exd.13286

21 A. Tewari, K. Grys, J. Kollet, R. Sarkany, A.R. YoungUpregulation of mmp 12 and its activity by uva 1 in human skin: potential implications for photoaging J Invest Dermatol, 134 (10) (2014), pp. 2598-2609, 10.1038/jid.2014.173

22 Z. Xu, Q. Sui, A. Li, et al.How to detect small microplastics (20-100 mum) in freshwater, municipal wastewaters and landfill leachates? A trial from sampling to identification Sci Total Environ, 733 (2020), Article 139218, 10.1016/j.scitotenv.2020.139218

23 S. Voss, A. Ernst, M. Erlebach, et al.Effects of a dual-filter-based cerebral embolic protection device in transcatheter aortic valve replacement on cerebral oxygen saturation: a prospective pilot study J Card Surg, 36 (4) (2021), pp. 1241-1248, 10.1111/jocs.15355

24 A.S. Shah, A. Akhmerov, N. Gupta, T. Chakravarty, R.R. Makkar, A. AzizzadehUse of a dual-filter cerebral embolic protection device in thoracic endovascular aortic repair Ann Vasc Surg, 65 (2020), pp. 51-54, 10.1016/j.avsg.2020.01.077

25 M. Assad, S.M. Howell, J. Liu, et al.The effect of lipoaspirate processing technique on complications in autologous fat grafting for breast reconstruction: a propensity score analysis study Aesthetic Surg J, 41 (10) (2021), pp. P1303-P1309, 10.1093/asj/sjab235

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据